FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implant, Anti-Gastroesophageal Reflux

PMA: P100049 · Supplement: S038 · Decision Oct 8, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P100049 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Implant, Anti-Gastroesophageal Reflux
Trade Name
LINX Reflux Management System
PMA Number
P100049
Supplement Number
S038
Device Class
FDA Class 3
Product Code
LEI
Generic Name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Medical Specialty
Unknown
Advisory Committee
Gastroenterology, Urology
Decision
Approved
Decision Code
APPR
Decision Date
October 8, 2025
Date Received
December 20, 2024
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

for the manufacturing site change.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LEI Implant, Anti-Gastroesophageal Reflux